Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PAX3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | ATAT1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | ZNF700 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | PRDX5 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | TCEAL3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | FNDC10 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | IFITM10 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | SLC22A5 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | RBM33 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | MRPS16 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |